Resource Guide

    CHAMPVA and GLP-1 Drugs: Ozempic, Mounjaro, Wegovy, Zepbound

    CHAMPVA covers some GLP-1 drugs for diabetes, sleep apnea, MASH, or heart risk, but not for weight loss. Here's the current list and prior authorization rules.

    CHAMPVA Resources2 min readReviewed by ValorWellUpdated October 14, 2026

    The short answer

    It depends on the drug and the diagnosis. VA lists Mounjaro, Ozempic, Trulicity, and Victoza for type 2 diabetes; Zepbound for moderate to severe sleep apnea; and Wegovy for MASH or preventing heart attack and stroke after prior events. Wegovy and Zepbound need prior authorization through OptumRx. No GLP-1 is covered for weight loss alone.

    The current list

    From VA's CHAMPVA provider page:

    UseDrugPrior authorization
    Type 2 diabetesMounjaro, Ozempic, Trulicity, VictozaNot the special GLP-1 requirement, though other pharmacy rules can apply
    Moderate to severe obstructive sleep apneaZepboundYes, plus a sleep study within the past 12 months
    MASH (a fatty liver disease) or preventing major heart eventsWegovyYes
    Weight loss aloneNoneNot covered

    Prior authorization for Wegovy and Zepbound goes to OptumRx at 844-403-1029. That's separate from CHAMPVA's medical preauthorization line.

    This is a fast-changing area. Check VA's page before relying on coverage.

    Why isn't weight loss covered?

    38 CFR 17.272(a)(22) excludes nonsurgical weight-loss treatment, including prescription drugs. So the same drug can be covered for one diagnosis and not another. The prescription has to be for the listed condition.

    More here: CHAMPVA weight-loss coverage.

    What about Rybelsus?

    VA's pages don't match. VA's Meds by Mail list includes Rybelsus for type 2 diabetes, but the CHAMPVA provider page doesn't list it. Ask the pharmacy or prescriber to confirm before relying on payment.

    Zepbound for sleep apnea

    The sleep apnea has to be moderate to severe and confirmed by a sleep study within the past 12 months, and prior authorization is required. If your sleep study is older, you may need a new one.

    Wegovy for MASH or heart risk

    Prior authorization is required. VA describes the heart use as prevention for people who've already had a major cardiovascular event. The prescriber should send documentation of the diagnosis and answer any follow-up questions from OptumRx.

    If a GLP-1 prescription is rejected

    1. Check the diagnosis on the prescription. Does it match VA's list?
    2. Check prior authorization for Wegovy or Zepbound.
    3. Check the sleep study date for Zepbound.
    4. Separate pharmacy problems from coverage decisions. Routing, other insurance, and missing approval are different fixes.
    5. Get the exact rejection reason before trying again.

    Does Meds by Mail change anything?

    No. Meds by Mail is a way to get the drug, not a way around the coverage rules. You also need no other drug coverage to use it. More here: CHAMPVA prescription coverage.

    Frequently asked questions

    Need care?

    Find the care path that fits your situation.